GlassScriptPhysician profile
Aarti Nasta
NPI 1346447893
$1,522.68
in general payments reported to CMS, 2019-2025
20 companies · $255 in 2025
The $255 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $187 · 2021: $282 · 2022: $325 · 2023: $116 · 2024: $209 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $580.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $579.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $232.20 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $220.08 | 2021-2025 | |
| Cranial Technologies, INC | $180.26 | 2020-2025 | Doc Band |
| Kaleo, INC. | $156.91 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $122.62 | 2021-2025 | Gardasil 9, Vaxelis, Gardasil |
| Bausch Health US, LLC | $96.87 | 2020-2023 | Aplenzin |
| Hologic Sales and Service, LLC | $87.03 | 2019-2023 | Acessa Provu System |
| Sanofi Pasteur INC. | $71.89 | 2019-2025 | |
| Roche Diagnostics Corporation | $57.79 | 2019 | |
| Seqirus USA INC | $46.50 | 2024-2025 | Flucelvax |
| Neurocrine Biosciences, INC. | $42.60 | 2024 | |
| Abbvie INC. | $39.58 | 2020 | |
| Boston Scientific Corporation | $25.17 | 2021 | |
| Urovant Sciences INC | $24.76 | 2021 | |
| Ferring Pharmaceuticals INC. | $24.37 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $23.40 | 2022 | |
| Octapharma USA, INC. | $21.02 | 2025 | Fibryga |
| Therapeuticsmd, INC. | $17.49 | 2021 | |
| Coloplast Corp | $16.24 | 2021 | |
| Axonics, INC. | $15.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aarti Nasta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.